Position in AKAN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,917
-$10,832 QoQ
Shares Held
3,472
+64.3% QoQ
Ownership
0.642%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $132,018,496 across 28 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
98,864 | $53,567,481 | |
| 2 | ZTS |
Zoetis Inc.
|
241,369 | $17,344,776 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,081,523 | $10,815,230 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
295,918 | $10,025,701 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
387,530 | $7,820,355 | |
| 6 | HLN |
Haleon plc
|
682,281 | $6,365,681 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
63,008 | $5,215,802 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
278,706 | $4,467,657 |
All Filings in AKAN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,917 | 15,641 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $21,749 | 47,592 | Shares | Defined | 2026-02-12 | |
| 2024-03-31 | $2,017 | 17,245 | Shares | Defined | 2024-05-13 | |
| 2022-12-31 | $3 | 23,243 | Shares | Defined | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||